Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1Phase 3 1

Status

Recruiting 12Completed 9Unknown 6Not yet recruiting 5Terminated 2Active not recruiting 2Withdrawn 1

Sponsor Class

INDUSTRY 3OTHER_GOV 1OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 17Other solid neoplasm 9Thoracic 8Breast 6Gynecologic 5Sarcoma 3Head & Neck 3Other hematologic neoplasm 2Tumor-Agnostic 1Plasma cell 1Lymphoid 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Uterine Cervical Neoplasms 2Advanced Endometrial Cancer 2Ovarian Neoplasms 1Lung Neoplasms 1

Interventions

Paclitaxel 24Carboplatin 18Bevacizumab 14Cisplatin 10pembrolizumab 7fluzoparib 7Radiotherapy 6Drug Therapy 6apatinib 5Topotecan 5Magnetic Resonance Spectroscopy 5Injections 5liposomal doxorubicin 4lenvatinib 4famitinib 4camrelizumab 4Tirzepatide 4Specimen Handling 4Platinum 4Observation 4Gemcitabine 4Brachytherapy 4toripalimab 3olaparib 3dostarlimab 3anlotinib 3Watchful Waiting 3Therapeutics 3Surveys and Questionnaires 3Neoadjuvant Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Injections × Gynecologic × Clear all
NCT07469202 2026-03-13

CYTALUX Dose Extension Study

On Target Laboratories, LLC

Phase 4 Not yet recruiting
106 enrolled
GynecologicThoracic

Lung Neoplasms, Ovarian Neoplasms

NCT05077215 2025-12-08

Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial Cancer

Evergreen Therapeutics, Inc.

Phase 3 Not yet recruiting
450 enrolled
Gynecologic

Advanced Endometrial Cancer

NCT05106127 2025-12-08

Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem

Evergreen Therapeutics, Inc.

Phase 2 Not yet recruiting
28 enrolled
Gynecologic

Advanced Endometrial Cancer

NCT06426056 2024-05-23

Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial.

Peking University Third Hospital

Phase 2 Not yet recruiting
64 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT06149767 2023-11-29

Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer

Fujian Cancer Hospital

Phase 2 Not yet recruiting
26 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡